Ciprofloxacin resistance in nontypable Haemophilus influenzae clinical isolates

Author(s):  
Amaia Aguirre-Quiñonero ◽  
Andrés Canut
Chemotherapy ◽  
2004 ◽  
Vol 50 (6) ◽  
pp. 265-275 ◽  
Author(s):  
Satoshi Yoshizumi ◽  
Yoshie Takahashi ◽  
Yoshinari Watanabe ◽  
Eiichi Okezaki ◽  
Yoshikazu Ishii ◽  
...  

Drugs ◽  
1995 ◽  
Vol 49 (Supplement 2) ◽  
pp. 175-176 ◽  
Author(s):  
G. Corti ◽  
F. Paradisi ◽  
E. Giganti ◽  
G. Buffini ◽  
E. Tortoli ◽  
...  

BMJ ◽  
1987 ◽  
Vol 295 (6591) ◽  
pp. 176-179 ◽  
Author(s):  
M Powell ◽  
C Koutsia-Carouzou ◽  
D Voutsinas ◽  
A Seymour ◽  
J D Williams

Gene Reports ◽  
2020 ◽  
Vol 18 ◽  
pp. 100556
Author(s):  
Seyed Davar Siadat ◽  
Azad Khaledi ◽  
Fereshteh Shahcheraghi ◽  
Somaye Rashki ◽  
Maryam Arfaatabar

1998 ◽  
Vol 42 (8) ◽  
pp. 2138-2140 ◽  
Author(s):  
Arthur L. Barry ◽  
Peter C. Fuchs ◽  
Steven D. Brown

ABSTRACT The ketolide HMR 3647 (previously RU 66647) was evaluated against 2,563 recent clinical isolates of gram-positive pathogens and 200Haemophilus influenzae isolates. HMR 3647 was active against macrolide-resistant streptococci, including pneumococci, but was not active against macrolide- or lincosamide-resistant staphylococci. Against H. influenzae, the potency of HMR 3647 was similar to that of azithromycin.


Sign in / Sign up

Export Citation Format

Share Document